A personalized #mRNA #cancer #vaccine combined with the #immunotherapy #Keytruda succeeded in a late-stage trial for the deadly skin cancer #melanoma, its makers said Wednesday, potentially opening up a new way of treating the #disease.
The study is ongoing, but interim results found the treatment, #intismeran, met both its primary target of reducing cancer recurrence & its secondary goal of keeping cancers from spreading to other parts of the body.
#PublicHealth #health #science #medicine